WASHINGTON , Nov. 21, 2024 /PRNewswire/ -- The American Pharmacists Association (APhA) announces a significant leadership transition within its autonomous division of the Board of Pharmacy Specialties (BPS). William Ellis , MS, RPh, ICE-CCP—after an impactful 14-year tenure as Executive Director of BPS—is retiring, effective January 10, 2025 .
Bill's leadership has been instrumental in the evolution and growth of BPS. His commitment to advancing pharmacy board certification has left an indelible mark on the profession. Prior to his time at BPS, Ellis served as CEO and Executive Director of the APhA Foundation for nearly 13 years, where he spearheaded research initiatives and impactful programs that earned national acclaim.
His extensive career also includes over a decade as Executive Vice President of the Pennsylvania Society of Health-System Pharmacists and a successful completion of the American Society of Health-System Pharmacists' Executive Residency in Association Management. Ellis's influence extends beyond BPS, having held leadership roles in various professional organizations, including serving as Administrative Commissioner and Chair of the National Commission on Certifying Agencies and as a board member of the Institute for Credentialing Excellence. "On behalf of the board, we would like to extend our sincerest gratitude, appreciation, and respect to Bill for his exceptional leadership of BPS.
Over the past decade, the success and growth of BPS have been signifi.